Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia

Giovanni Murialdo, Stefano Fonzi, Francesco Torre, Patrizia Costelli, Giampiero Solinas, Pietro Tosca, Enrica Di Paolo, Sabino Porro, Francesco Zerbi, Alessandro Poll Eri

Research output: Contribution to journalArticle

Abstract

Alterations of neuroendocrinological indices determined by the impaired regulating effects of cholinergic neurotransmission have been described in primary dementia. In this study we have evaluated the effects of acetylcholinesterase inhibition by pyridostigmine on growth hormone (GH), adrenocorticotropic hormone (ACTH) and cortisol secretion and on their responses to GH- releasing hormone (GHRH) and corticotropin-releasing hormone (CRH) in 7 patients with primary degenerative dementia and in 8 sex- and age-matched controls. Demented subjects showed higher cortisol basal levels and lower ACTH levels than controls. Pyridostigmine increased the GH response to GHRH in both groups, the effect being significantly enhanced in patients. An increase of ACTH and cortisol levels was found in both groups after pyridostigmine and CRH administration. Pyridostigmine pretreatment significantly increased the ACTH response to CRH in controls but not in patients. The obtained data may indicate that a muscarinic receptor upregulation and an impairment of somatostatinergic function are operative in the regulation of GH secretion in dementia. An underlying hyperactivity of the hypothalamic- pituitary-adrenal axis impairs the responses of ACTH and cortisol to CRH in this disorder.

Original languageEnglish
Pages (from-to)177-183
Number of pages7
JournalNeuropsychobiology
Volume28
Issue number4
DOIs
Publication statusPublished - 1987

Fingerprint

Pyridostigmine Bromide
Growth Hormone-Releasing Hormone
Corticotropin-Releasing Hormone
Adrenocorticotropic Hormone
Growth Hormone
Dementia
Hydrocortisone
Muscarinic Receptors
Acetylcholinesterase
Synaptic Transmission
Cholinergic Agents
Up-Regulation
Hormones

Keywords

  • Adrenocorticotropic hormone
  • Cholinergic system
  • Corticotropin releasing-hormone
  • Cortisol
  • Dementia
  • Growth hormone
  • Growth hormone-releasing hormone
  • Pyridostigmine

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Psychology(all)

Cite this

Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia. / Murialdo, Giovanni; Fonzi, Stefano; Torre, Francesco; Costelli, Patrizia; Solinas, Giampiero; Tosca, Pietro; Di Paolo, Enrica; Porro, Sabino; Zerbi, Francesco; Poll Eri, Alessandro.

In: Neuropsychobiology, Vol. 28, No. 4, 1987, p. 177-183.

Research output: Contribution to journalArticle

Murialdo, G, Fonzi, S, Torre, F, Costelli, P, Solinas, G, Tosca, P, Di Paolo, E, Porro, S, Zerbi, F & Poll Eri, A 1987, 'Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia', Neuropsychobiology, vol. 28, no. 4, pp. 177-183. https://doi.org/10.1159/000119020
Murialdo, Giovanni ; Fonzi, Stefano ; Torre, Francesco ; Costelli, Patrizia ; Solinas, Giampiero ; Tosca, Pietro ; Di Paolo, Enrica ; Porro, Sabino ; Zerbi, Francesco ; Poll Eri, Alessandro. / Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia. In: Neuropsychobiology. 1987 ; Vol. 28, No. 4. pp. 177-183.
@article{e6ae991f875e4565a70a03632543a67e,
title = "Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia",
abstract = "Alterations of neuroendocrinological indices determined by the impaired regulating effects of cholinergic neurotransmission have been described in primary dementia. In this study we have evaluated the effects of acetylcholinesterase inhibition by pyridostigmine on growth hormone (GH), adrenocorticotropic hormone (ACTH) and cortisol secretion and on their responses to GH- releasing hormone (GHRH) and corticotropin-releasing hormone (CRH) in 7 patients with primary degenerative dementia and in 8 sex- and age-matched controls. Demented subjects showed higher cortisol basal levels and lower ACTH levels than controls. Pyridostigmine increased the GH response to GHRH in both groups, the effect being significantly enhanced in patients. An increase of ACTH and cortisol levels was found in both groups after pyridostigmine and CRH administration. Pyridostigmine pretreatment significantly increased the ACTH response to CRH in controls but not in patients. The obtained data may indicate that a muscarinic receptor upregulation and an impairment of somatostatinergic function are operative in the regulation of GH secretion in dementia. An underlying hyperactivity of the hypothalamic- pituitary-adrenal axis impairs the responses of ACTH and cortisol to CRH in this disorder.",
keywords = "Adrenocorticotropic hormone, Cholinergic system, Corticotropin releasing-hormone, Cortisol, Dementia, Growth hormone, Growth hormone-releasing hormone, Pyridostigmine",
author = "Giovanni Murialdo and Stefano Fonzi and Francesco Torre and Patrizia Costelli and Giampiero Solinas and Pietro Tosca and {Di Paolo}, Enrica and Sabino Porro and Francesco Zerbi and {Poll Eri}, Alessandro",
year = "1987",
doi = "10.1159/000119020",
language = "English",
volume = "28",
pages = "177--183",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia

AU - Murialdo, Giovanni

AU - Fonzi, Stefano

AU - Torre, Francesco

AU - Costelli, Patrizia

AU - Solinas, Giampiero

AU - Tosca, Pietro

AU - Di Paolo, Enrica

AU - Porro, Sabino

AU - Zerbi, Francesco

AU - Poll Eri, Alessandro

PY - 1987

Y1 - 1987

N2 - Alterations of neuroendocrinological indices determined by the impaired regulating effects of cholinergic neurotransmission have been described in primary dementia. In this study we have evaluated the effects of acetylcholinesterase inhibition by pyridostigmine on growth hormone (GH), adrenocorticotropic hormone (ACTH) and cortisol secretion and on their responses to GH- releasing hormone (GHRH) and corticotropin-releasing hormone (CRH) in 7 patients with primary degenerative dementia and in 8 sex- and age-matched controls. Demented subjects showed higher cortisol basal levels and lower ACTH levels than controls. Pyridostigmine increased the GH response to GHRH in both groups, the effect being significantly enhanced in patients. An increase of ACTH and cortisol levels was found in both groups after pyridostigmine and CRH administration. Pyridostigmine pretreatment significantly increased the ACTH response to CRH in controls but not in patients. The obtained data may indicate that a muscarinic receptor upregulation and an impairment of somatostatinergic function are operative in the regulation of GH secretion in dementia. An underlying hyperactivity of the hypothalamic- pituitary-adrenal axis impairs the responses of ACTH and cortisol to CRH in this disorder.

AB - Alterations of neuroendocrinological indices determined by the impaired regulating effects of cholinergic neurotransmission have been described in primary dementia. In this study we have evaluated the effects of acetylcholinesterase inhibition by pyridostigmine on growth hormone (GH), adrenocorticotropic hormone (ACTH) and cortisol secretion and on their responses to GH- releasing hormone (GHRH) and corticotropin-releasing hormone (CRH) in 7 patients with primary degenerative dementia and in 8 sex- and age-matched controls. Demented subjects showed higher cortisol basal levels and lower ACTH levels than controls. Pyridostigmine increased the GH response to GHRH in both groups, the effect being significantly enhanced in patients. An increase of ACTH and cortisol levels was found in both groups after pyridostigmine and CRH administration. Pyridostigmine pretreatment significantly increased the ACTH response to CRH in controls but not in patients. The obtained data may indicate that a muscarinic receptor upregulation and an impairment of somatostatinergic function are operative in the regulation of GH secretion in dementia. An underlying hyperactivity of the hypothalamic- pituitary-adrenal axis impairs the responses of ACTH and cortisol to CRH in this disorder.

KW - Adrenocorticotropic hormone

KW - Cholinergic system

KW - Corticotropin releasing-hormone

KW - Cortisol

KW - Dementia

KW - Growth hormone

KW - Growth hormone-releasing hormone

KW - Pyridostigmine

UR - http://www.scopus.com/inward/record.url?scp=0027429205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027429205&partnerID=8YFLogxK

U2 - 10.1159/000119020

DO - 10.1159/000119020

M3 - Article

C2 - 8272199

AN - SCOPUS:0027429205

VL - 28

SP - 177

EP - 183

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 4

ER -